F. Sejourne et al., MECHANISMS OF VASODILATION ELICITED BY VIP IN STERICALLY STABILIZED LIPOSOMES IN-VIVO, American journal of physiology. Regulatory, integrative and comparative physiology, 42(1), 1997, pp. 287-292
Mechanisms of vasodilation elicited by VIP in sterically stabilized li
posomes in vivo. Am. J. Physiol. 273 (Regulatory Integrative Comp. Phy
siol. 42): R287-R292, 1997.-The purpose of this study was to begin to
determine the mechanisms underlying vasodilation elicited by vasoactiv
e intestinal peptide (VIP) in sterically stabilized Liposomes (SSL) in
the in situ peripheral microcirculation. Using intravital microscopy,
we found that suffusion of VIP in SSL (0.42 and 0.85 nmol) onto the h
amster cheek pouch for 1 h elicited significant and prolonged concentr
ation-dependent vasodilation (P < 0.05). Suffusion of VIP in SSL (0.1
nmol) for 7 min elicited a qualitatively similar response, although it
s magnitude was significantly smaller than that elicited by 1 h of suf
fusion of VIP in SSL (P < 0.05). The VIP-receptor antagonist VIP-(10-2
8), but not the amino-terminal fragment VIP-(1-12), significantly atte
nuated and delayed the onset of VIP in SSL-induced vasodilation (P < 0
.05). The nitric oxide (NO) synthase inhibitor N-G-nitro-L-arginine me
thyl ester (L-NAME), but not N-G-nitro-D-arginine methyl ester (D-NAME
), abrogated VIP in SSL-induced responses. We conclude that VIP in SSL
elicits significant and prolonged vasodilation in the in situ periphe
ral microcirculation, which is specific, partly receptor dependent, an
d partly transduced by the L-arginine/NO biosynthetic pathway.